Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)
Clinical trial NCT01405937 · COMPLETED
Trial details
- NCT number
- NCT01405937
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-29
- Primary completion
- 2013-02-26
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.